ArticleFrontiers in genetics2023

Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study.

Honglin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.